(Q33901227)

29 July 2017

0 references

Irreversible pulmonary hypertension associated with the use of interferon alpha for chronic hepatitis C. (English)

1 reference

29 July 2017

main subject

pulmonary hypertension

1 reference

1 reference

Sonu Dhillon

1

1 reference

29 July 2017

Anshul Kaker

2

1 reference

29 July 2017

Aneil Dosanjh

3

1 reference

29 July 2017

Deepa Japra

4

1 reference

29 July 2017

David H Vanthiel

5

1 reference

29 July 2017

publication date

22 April 2010

1 reference

Digestive Diseases and Sciences

29 July 2017

published in

1 reference

29 July 2017

volume

55

1 reference

29 July 2017

issue

6

1 reference

29 July 2017

page(s)

1785-1790

1 reference

https://scigraph.springernature.com/pub.10.1007/s10620-010-1220-7

29 July 2017

exact match

0 references

cites work

Virus interference. I. The interferon

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2882564

Pulmonary side effects of interferon‐α therapy in patients with hematological malignancies

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2882564

Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2882564

Interstitial pneumonitis in a patient treated with alpha-interferon and ribavirin for hepatitis C infection.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2882564

Heart diseases affecting the liver and liver diseases affecting the heart

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2882564

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2882564

Exacerbation of symptoms of autoimmune disease in patients receiving alpha-interferon therapy

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2882564

Idiopathic Pulmonary Fibrosis and High Prevalence of Serum Antibodies to Hepatitis C Virus

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2882564

Idiopathic pulmonary fibrosis and hepatitis C virus infection

5 July 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS10620-010-1220-7

Dilated Cardiomyopathy Associated With Hepatitis C Virus Infection

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS10620-010-1220-7

Retreating chronic hepatitis C with daily interferon alfacon-1/ribavirin after nonresponse to pegylated interferon/ribavirin: DIRECT results

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2882564

Expression of human herpesvirus 8 in primary pulmonary hypertension

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2882564

Pegylated interferon and ribavirin-induced interstitial pneumonitis with ARDS.

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2882564

Bronchoalveolar lavage fluid analysis in individuals with chronic hepatitis C.

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2882564

Pulmonary artery hypertension during interferon-alpha therapy for chronic myelogenous leukemia

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2882564

Heterozygous germline mutations in BMPR2, encoding a TGF-beta receptor, cause familial primary pulmonary hypertension

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2882564

Interferon-alpha elevates pulmonary blood pressure in sheep--the role of thromboxane cascade.

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2882564

Molecular heterogeneity in complete cytogenetic responders after interferon-alpha therapy for chronic myelogenous leukemia: low levels of minimal residual disease are associated with continuing remission. German CML Study Group and the UK MRC CML St

29 October 2018

1 reference

12 December 2020

Pleural effusion during interferon treatment for chronic hepatitis C

1 reference

12 December 2020

Primary pulmonary hypertension and cirrhosis: are they related?

1 reference

12 December 2020

Changes in results of Gallium-67-citrate scanning after interferon therapy for chronic hepatitis C

1 reference

12 December 2020

A case of interstitial pneumonitis associated with natural alpha-interferon therapy for myelofibrosis

1 reference

12 December 2020

Interferon alfa-2b combined with cytarabine versus interferon alone in chronic myelogenous leukemia. French Chronic Myeloid Leukemia Study Group

1 reference

12 December 2020

Severe exacerbation of asthma: a new side effect of interferon-alpha in patients with asthma and chronic hepatitis C

1 reference

12 December 2020

Interferon-alpha therapy associated with the development of sarcoidosis

1 reference

12 December 2020

10.1007/S10620-010-1220-7

Identifiers

DOI

1 reference

Dimensions Publication ID

29 July 2017

0 references

1 reference

29 July 2017

1 reference